miRNAs mediated drug resistance in hematological malignancies

SP da Silva, HR Caires, R Bergantim… - Seminars in Cancer …, 2022 - Elsevier
Despite improvements in the therapeutic approaches for hematological malignancies in the
last decades, refractory disease still occurs, and cancer drug resistance still remains a major …

[HTML][HTML] MiRNA dysregulation in childhood hematological cancer

J Carvalho de Oliveira, G Molinari Roberto… - International journal of …, 2018 - mdpi.com
For decades, cancer biology focused largely on the protein-encoding genes that have clear
roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome …

[HTML][HTML] MicroRNA-155 expression and function in AML: An evolving paradigm

N Narayan, CP Bracken, PG Ekert - Experimental hematology, 2018 - Elsevier
Highlights•MicroRNAs are dysregulated in acute myeloid leukemia (AML).•MicroRNA
expression profiles are useful for disease classification and prognosis.•Expression levels of …

[HTML][HTML] Multi-modality analysis improves survival prediction in enucleated uveal melanoma patients

W Drabarek, S Yavuzyigitoglu… - … & visual science, 2019 - arvojournals.org
Purpose: Uveal melanoma (UM) is characterized by multiple chromosomal rearrangements
and recurrent mutated genes. The aim of this study was to investigate if copy number …

[HTML][HTML] MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p …

PP Leoncini, P Vitullo, S Reddel… - Oncology …, 2022 - spandidos-publications.com
Novel therapeutic strategies are needed for paediatric patients affected by Acute Myeloid
Leukaemia (AML), particularly for those at high-risk for relapse. MicroRNAs (miRs) have …

Identification of circular RNA Circ_0003256 as a novel player in pediatric acute myeloid leukemia

J Liu, B Qiu - Journal of pediatric hematology/oncology, 2023 - journals.lww.com
Background: Aberrant expression of circular RNAs (circRNAs) is tightly associated with the
pathogenesis of human cancers, including pediatric acute myeloid leukemia (AML). In this …

[HTML][HTML] Exploration of differentially expressed mRNAs and miRNAs for pediatric acute myeloid leukemia

Q Wang, C Yue, Q Liu, X Che - Frontiers in Genetics, 2022 - frontiersin.org
Background: To establish a comprehensive differential gene profile for pediatric acute
myeloid leukemia patients (pAML) based on two independent databases and verify the …

[PDF][PDF] Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemia

V Gaur, S Chaudhary, A Tyagi, S Agarwal… - British Journal of …, 2020 - academia.edu
Correspondence e90© 2019 British Society for Haematology and John Wiley & Sons Ltd
British Journal of Haematology, 2020, 188, e80–e112 identification of differentially …

miR-144-3p Derived from Bone Marrow Mesenchymal Stem Cells (BMSCs) Restrains the Drug Resistance of Acute Myeloid Leukemia (AML)

J Wu, Y Xie, L Han - Journal of Biomaterials and Tissue …, 2022 - ingentaconnect.com
This study assessed whether miR-144-3p derived from BMSCs restrains the drug resistance
of AML. Our study intends to assess miR-144-3p's role in AML drug resistance. Drug …

Small Non-Coding RNAs in Regulation of Course and Therapeutic Efficacy in Acute Myeloid Leukemia

OV Klimenko - Myeloid Leukemia, 2017 - books.google.com
Small non-coding RNAs (sncRNAs) are small regulatory molecules, which play key roles in
fine-tune of all cell functions. In late 1970s and early 1980s, it was first determined that non …